McLaughlin JP - Search Results

1

The macrocyclic peptide natural product CJ-15,208 is orally active and prevents reinstatement of extinguished cocaine-seeking behavior.

Aldrich JV, Senadheera SN, Ross NC, Ganno ML, Eans SO, McLaughlin JP. Aldrich JV, et al. Among authors: mclaughlin jp. J Nat Prod. 2013 Mar 22;76(3):433-8. doi: 10.1021/np300697k. Epub 2013 Jan 17. J Nat Prod. 2013. PMID: 23327691 Free PMC article.

2

Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn.

Carey AN, Borozny K, Aldrich JV, McLaughlin JP. Carey AN, et al. Among authors: mclaughlin jp. Eur J Pharmacol. 2007 Aug 13;569(1-2):84-9. doi: 10.1016/j.ejphar.2007.05.007. Epub 2007 May 13. Eur J Pharmacol. 2007. PMID: 17568579 Free PMC article.

3

Synthesis of cyclic tetrapeptide CJ 15,208: a novel kappa opioid receptor antagonist.

Kulkarni SS, Ross NC, McLaughlin JP, Aldrich JV. Kulkarni SS, et al. Among authors: mclaughlin jp. Adv Exp Med Biol. 2009;611:269-70. doi: 10.1007/978-0-387-73657-0_121. Adv Exp Med Biol. 2009. PMID: 19400188 No abstract available.

4

Peptide kappa opioid receptor ligands: potential for drug development.

Aldrich JV, McLaughlin JP. Aldrich JV, et al. Among authors: mclaughlin jp. AAPS J. 2009 Jun;11(2):312-22. doi: 10.1208/s12248-009-9105-4. Epub 2009 May 9. AAPS J. 2009. PMID: 19430912 Free PMC article. Review.

5

Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action.

Aldrich JV, Patkar KA, McLaughlin JP. Aldrich JV, et al. Among authors: mclaughlin jp. Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18396-401. doi: 10.1073/pnas.0910180106. Epub 2009 Oct 19. Proc Natl Acad Sci U S A. 2009. PMID: 19841255 Free PMC article.

6

Novel opioid cyclic tetrapeptides: Trp isomers of CJ-15,208 exhibit distinct opioid receptor agonism and short-acting κ opioid receptor antagonism.

Ross NC, Reilley KJ, Murray TF, Aldrich JV, McLaughlin JP. Ross NC, et al. Among authors: mclaughlin jp. Br J Pharmacol. 2012 Feb;165(4b):1097-108. doi: 10.1111/j.1476-5381.2011.01544.x. Br J Pharmacol. 2012. PMID: 21671905 Free PMC article.

7

Unexpected opioid activity profiles of analogues of the novel peptide kappa opioid receptor ligand CJ-15,208.

Aldrich JV, Kulkarni SS, Senadheera SN, Ross NC, Reilley KJ, Eans SO, Ganno ML, Murray TF, McLaughlin JP. Aldrich JV, et al. Among authors: mclaughlin jp. ChemMedChem. 2011 Sep 5;6(9):1739-45. doi: 10.1002/cmdc.201100113. Epub 2011 Jul 14. ChemMedChem. 2011. PMID: 21761566 Free PMC article.

8

Peptides derived from the prohormone proNPQ/spexin are potent central modulators of cardiovascular and renal function and nociception.

Toll L, Khroyan TV, Sonmez K, Ozawa A, Lindberg I, McLaughlin JP, Eans SO, Shahien AA, Kapusta DR. Toll L, et al. Among authors: mclaughlin jp. FASEB J. 2012 Feb;26(2):947-54. doi: 10.1096/fj.11-192831. Epub 2011 Oct 28. FASEB J. 2012. PMID: 22038051 Free PMC article.

9

Synthesis of CJ-15,208, a novel κ-opioid receptor antagonist.

Ross NC, Kulkarni SS, McLaughlin JP, Aldrich JV. Ross NC, et al. Among authors: mclaughlin jp. Tetrahedron Lett. 2010 Sep 20;51(38):5020-5023. doi: 10.1016/j.tetlet.2010.07.086. Tetrahedron Lett. 2010. PMID: 22865937 Free PMC article.

10

Opioid Peptides: Potential for Drug Development.

Aldrich JV, McLaughlin JP. Aldrich JV, et al. Among authors: mclaughlin jp. Drug Discov Today Technol. 2012;9(1):e23-e31. doi: 10.1016/j.ddtec.2011.07.007. Drug Discov Today Technol. 2012. PMID: 23316256 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters